RE:RE:RE:RE:RE:RE:Merger info: no packages sent out, nothing on SEDARCiao, "and essentially the takeover of CEAPRO at below liquidation value"
Ciao still hasn't figured out that CZO shareholders get 50% of the shares of the new company. The value of the new company is confidential. Gilles knows the AEZS diagnostic deals that have been discussed and PGX deals that have been discussed. Gilles is in the catbird seat at both companies. The plan, near-term revenue generating opportunities in CZO's pipeline that AEZS's capital is to be used for also hasn't been disclosed. There has never been any data released for CZO's avenanthramide pill. One or more of AEZS's pipeline programs also appears near a clinical trial go decision. Ciao doesn't have any idea what he is talking about. The value of this deal is to be disclosed with events in the future. What we know currently is that CZO shareholders are to get half of whatever the value is and that Ronnie Miller is "thrilled" and believes this is the best option for shareholders.